GHRHR-SV1抗体的制备及其蛋白在黑色素瘤细胞中的表达

doi:10.13481/j.1671-587x.20160637

吉林大学学报(医学版) ›› 2016, Vol. 42 ›› Issue (06): 1237-1242.doi: 10.13481/j.1671-587x.20160637

GHRHR-SV1抗体的制备及其蛋白在黑色素瘤细胞中的表达

郭晓兰, 谭茵, 陈文生, 林玉茵, 戴建威

广州医科大学生物学实验中心, 广东广州 511436

收稿日期:2016-03-22 出版日期:2016-11-28 发布日期:2016-12-02
通讯作者: 戴建威,副教授,硕士研究生导师(Tel:020-37103208,E-mail:daijw@zhmu.edu.cn) E-mail:daijw@zhmu.edu.cn
作者简介:郭晓兰(1990-),女,广东省汕头市人,实验师助理,理学硕士,主要从事分子生物学方面的研究。
基金资助:
国家自然科学基金资助课题（31271476）；广东省广州市科技局科技计划项目资助课题（20150010076）；广东省教育厅人才项目资助课题（2013KJCX0155）；广东省自然科学基金资助课题（2016A030313601）

Preparation of GHRHR-SV1 antibodyand expression ofits protein in melanoma cells

GUO Xiaolan, TAN Yin, CHEN Wensheng, LIN Yuyin, DAI Jianwei

Center of Biology Experiment, Guangzhou Medical University, Guangzhou 511436, China

Received:2016-03-22 Online:2016-11-28 Published:2016-12-02

摘要/Abstract

摘要：

目的：制备生长激素释放激素受体剪接变异体1（GHRHR-SV1）抗体，并检测GHRHR-SV1蛋白在黑色素瘤细胞中的表达情况，为后续的肿瘤机制研究奠定基础。方法：设计GHRHR-SV1基因序列，将其插入质粒pET-32a（+）中，构建pET-GHRHR-SV1重组载体，经PCR及测序鉴定后，转入大肠杆菌BL21（DE3）中，分别加入0、0.5、1.0、1.5和2.0mmol·L^-1异丙基-β-D-硫代半乳糖苷（IPTG）；诱导1、2、4和6 h，并在37℃、30℃和25℃不同温度下进行诱导；观察目的蛋白表达的最佳IPTG浓度、时间和温度。亲和层析纯化重组蛋白，将纯化后的蛋白免疫家兔，制备兔多克隆抗体，ELISA法检测该抗体效价，Western blotting法检测GHRHR-SV1蛋白在黑色素瘤细胞系B16-F10中的表达情况。结果：重组载体pET-GHRHR-SV1构建成功。在IPTG浓度为2.0 mmol·L^-1时目的蛋白的表达量最高；IPTG诱导蛋白表达2 h时，蛋白表达量最大；当温度为25℃时，蛋白的表达量最大。诱导表达的蛋白相对分子质量约为24 000，纯化后纯度为80%，GHRHR-SV1抗体效价为1：1 600 000，B16-F10细胞中有GHRHR-SV1蛋白表达。结论：成功制备pET-GHRHR-SV1重组载体。GHRHR-SV1蛋白在IPTG浓度为2.0 mmol·L^-1、诱导时间为2 h和温度为25℃的条件下表达最佳。成功制备了高效价的GHRHR-SV1抗体。黑色素瘤细胞系中有GHRHR-SV1蛋白表达。

关键词: 生长激素释放激素受体剪接变异体1, 重组载体, 黑色素瘤, 抗体, 重组蛋白

Abstract:

Objective: To prepare the polyclonal antibody against growth hormone-releasing hormone receptor splice variant 1 (GHRHR-SV1),and to detect the expressions of GHRHR-SV1 protein in melanoma cells,and to lay a foundation for further study of the pathogenesis of tumor.Methods: The gene sequence of GHRHR-SV1 was designed and synthesized,and then cloned into pET-32 a (+)plasmid to construct the recombinant vector pET-GHRHR-SV1. After identification by PCR and sequencing,the recombinant plasmid was transformed into E.coli BL21 (DE3). Then 0,0.5,1.0,1.5, and 2.0 mmol·L^-1 isopropyl β-D-1-thiogalactopyranoside (IPTG) were added respectively to induce for 1,2,4, and 6 h at 37℃,30℃, and 25℃.The optimal dosage,time and temperature of IPTG of the target protein were observed.The protein was expressed under the optimal condition and purified by affinity chromatography.The polyclonal antibody was obtained by immunizing the rabbit with the purified protein.The titer was assayed by ELISA method.The expression of GHRHR-SV1 protein in B16-F10 cells was detected by Western blotting method.Results: The recombinant vector pET-GHRHR-SV1 was constructed successfully.The expression amount of GHRHR-SV1 protein was the highest when it was induced by 2.0 mmol·L^-1 IPTG for 2 h at 25℃. The relative molecular weight of induced protein was 24 000.After purification,the purity of protein was 80%.The GHRHR-SV1 antibody titer was 1:1 600 000.The GHRHR-SV1 protein was expressed in B16-F10 cells.Conclusion: The recombinant vector pET-GHRHR-SV1 is constructed successfully. The expression amount of GHRHR-SV1 protein in the condition of 2.0 mmol·L^-1 IPTG, 2 h-induction and at 25℃ is the highest.The high titer of ployclonal antibody is obtained.The GHRHR-SV1 protein can express in melanoma cells.

Key words: growth hormone-releasing hormone receptor splice variant 1, recombinant vector, melanoma, antibody, recombinant protein

中图分类号:

郭晓兰, 谭茵, 陈文生, 林玉茵, 戴建威. GHRHR-SV1抗体的制备及其蛋白在黑色素瘤细胞中的表达[J]. 吉林大学学报(医学版), 2016, 42(06): 1237-1242.

GUO Xiaolan, TAN Yin, CHEN Wensheng, LIN Yuyin, DAI Jianwei. Preparation of GHRHR-SV1 antibodyand expression ofits protein in melanoma cells[J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1237-1242.

参考文献

[1] Barabutis N,Schally AV. Growth hormone-releasing hormone:extrapituitary effects in physiology and pathology[J].Cell Cycle,2010,9(20):4110-4116.
[2] Mackrides N,Ganjei-Azar P,Perez R,et al.GHRH receptor expression in malignant mixed mullerian tumors:a potentially targetable biopredictor[J].Int J Gynecol Pathol,2016,35(2):142-146.
[3] Theophanous E,Petraki C,Scorilas A,et al.The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancer[J].Mol Med,2009,15(7/8):242-247.
[4] Dioufa N,Farmaki E,Schally AV,et al.Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas[J].Horm Cancer,2012,3(4):172-180.
[5] Klukovits A,Schally AV,Szalontay L,et al.Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers[J].Cancer,2012,118(3):670-680.
[6] Rekasi Z,Czompoly T,Schally AV,et al.Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers[J].Proc Natl Acad Sci U S A,2000,97(19):10561-10566.
[7] Toller GL,Horvath JE,Schally AV,et al.Development of a polyclonal antiserum for the detection of the isoforms of the receptors for human growth hormone-releasing hormone on tumors[J].Proc Natl Acad Sci U S A,2004,101(42):15160-15165.
[8] Kiaris H,Chatzistamou I,Papavassiliou AG,et al.Growth hormone-releasing hormone:not only a neurohormone[J].Trends Endocrinol Metab,2011,22(8):311-317.
[9] Barabutis N,Tsellou E,Schally AV,et al.Stimulation of proliferation of MCF-7 breast cancer cells by a transfected splice variant of growth hormone-releasing hormone receptor[J].Proc Natl Acad Sci U S A,2007,104(13):5575-5579.
[10] Mezey G,Treszl A,Schally AV,et al.Prognosis in human glioblastoma based on expression of ligand growth hormone-releasing hormone,pituitary-type growth hormone-releasing hormone receptor,its splicing variant receptors,EGF receptor and PTEN genes[J].J Cancer Res Clin Oncol,2014,140(10):1641-1649.
[11] Fahrenholtz CD,Rick FG,Garcia MI,et al.Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer[J].Proc Natl Acad Sci U S A,2014,111(3):1084-1089.
[12] Barabutis N,Siejka A,Schally AV,et al.Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor[J].J Mol Endocrinol,2010,44(2):127-134.
[13] Kiaris H,Chatzistamou I,Schally AV,et al.Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor[J].Proc Natl Acad Sci U S A,2003,100(16):9512-9517.
[14] Schally AV,Perez R,Block NL,et al.Potentiating effects of GHRH analogs on the response to chemotherapy[J].Cell Cycle,2015,14(5):699-704.
[15] Schally AV,Varga JL.Antagonists of growth hormone-releasing hormone in oncology[J].Comb Chem High Throughput Screen,2006,9(3):163-170.

GHRHR-SV1抗体的制备及其蛋白在黑色素瘤细胞中的表达

Preparation of GHRHR-SV1 antibodyand expression ofits protein in melanoma cells

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	王嘉欣, 武宁, 金顺子, 王彦君, 张萱. 人血浆抗谷胶蛋白抗体与不同年龄段精神分裂症患者发病的关联性[J]. 吉林大学学报(医学版), 2018, 44(06): 1263-1268.
[2]	赵振理, 畅继武, 孙光, 胡少华. AAX14401蛋白在人膀胱癌组织中的表达及其意义[J]. 吉林大学学报(医学版), 2018, 44(05): 1052-1055.
[3]	王晓宁, 赵震, 刘冰, 李凌波. 临床待输血患者RhE抗原和不规则抗体的检测及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(04): 801-805.
[4]	刘少伟, 姜欢, 王晓龙, 李梦红, 陈玉, 唐中元, 胡敏. 兔抗破骨细胞蛋白质酪氨酸磷酸酶多克隆抗体的制备和应用[J]. 吉林大学学报(医学版), 2018, 44(03): 661-666.
[5]	刘刚, 赵民学, 王德盛. 血清胃蛋白酶原、胃泌素17和幽门螺杆菌抗体检测在胃癌筛查中的应用[J]. 吉林大学学报(医学版), 2017, 43(06): 1182-1185.
[6]	尹芳蕊, 庞春艳, 吕凤凤, 张文兰, 赵剑波, 王永福. 抗核小体抗体、抗C1q抗体和抗双链DNA抗体在狼疮肾炎诊断中的意义[J]. 吉林大学学报(医学版), 2017, 43(04): 757-761.
[7]	林玉茵, 陈文生, 郭晓兰, 谭茵, 贺小松, 戴建威. 人生长激素释放激素受体剪接变异体1型对人肝癌细胞HepG2增殖的影响[J]. 吉林大学学报(医学版), 2017, 43(03): 474-478.
[8]	周广宇, 郭莹, 王婉宁, 尹敏, 王雪婷, 吴晨, 张艳. M型磷脂酶A2受体及其抗体在特发性膜性肾病诊断中作用的研究进展[J]. 吉林大学学报(医学版), 2017, 43(03): 651-655.
[9]	翟玥, 曲笑锋, 庞博, 李丽, 徐坤, 王梦涵, 高孜博, 宋佳音, 宋秀玲, 金明华. 副溶血性弧菌高免卵黄抗体的制备和不同提纯方法效果的比较[J]. 吉林大学学报(医学版), 2017, 43(02): 441-445.
[10]	黎文静, 徐萌, 郭丽双, 杨思睿, 刘金香. 儿童过敏性紫癜患者肺炎支原体抗体的检测及其临床意义[J]. 吉林大学学报(医学版), 2017, 43(01): 155-158.
[11]	王晓宁, 王震, 刘冰, 金玉顺, 张冬霞. 老年待输血患者Rh系统表型分型和不规则抗体检测及临床意义[J]. 吉林大学学报(医学版), 2016, 42(06): 1143-1146.
[12]	周广宇, 郭莹, 张力, 王雪婷, 吴晨. 他克莫司联合激素治疗特发性膜性肾病疗效及其抗PLA2R抗体对治疗的反应[J]. 吉林大学学报(医学版), 2016, 42(05): 937-941.
[13]	高雅, 王晓非. 胸腺基质淋巴细胞生成素在类风湿关节炎和有关节症状的系统性红斑狼疮患者外周血中的表达及其意义[J]. 吉林大学学报(医学版), 2016, 42(03): 556-560.
[14]	闫琰, 张茜, 马婧, 李建宁, 张薇, 孙玉宁. 犬博卡病毒非结构基因NP1多克隆抗体的制备与鉴定[J]. 吉林大学学报(医学版), 2015, 41(04): 864-869.
[15]	杨柳, 汪小菀, 王冰瑜, 宋润敏, 李江. GST-hZimp10融合蛋白的重组及抗体制备[J]. 吉林大学学报(医学版), 2015, 41(03): 656-661.